Cargando…
Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis
This study aimed to investigate the long-term outcomes of sulfonylurea (SU) use in patients with T2DM and compensated liver cirrhosis. From January 1, 2000, to December 31, 2012, we selected the data of 3781 propensity-score-matched SU users and nonusers from Taiwan’s National Health Insurance Resea...
Autores principales: | Yen, Fu-Shun, Lai, Jung-Nien, Wei, James Cheng-Chung, Chiu, Lu-Ting, Hwu, Chii-Min, Hou, Ming-Chih, Hsu, Chih-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735585/ https://www.ncbi.nlm.nih.gov/pubmed/33315940 http://dx.doi.org/10.1371/journal.pone.0243783 |
Ejemplares similares
-
Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
por: Yen, Fu-Shun, et al.
Publicado: (2021) -
Severe hypoglycemia in patients with liver cirrhosis and type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2023) -
Sulfonylurea Use in Patients with Type 2 Diabetes and COPD: A Nationwide Population-Based Cohort Study
por: Yen, Fu-Shun, et al.
Publicado: (2022) -
Liver-related long-term outcomes of alpha-glucosidase inhibitors in patients with diabetes and liver cirrhosis
por: Yen, Fu-Shun, et al.
Publicado: (2022) -
Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis
por: Yen, Fu‐Shun, et al.
Publicado: (2021)